DK1971865T3 - Fremgangsmåder til modulering af celleoverfladereceptorer til at forebygge eller reducere inflammation - Google Patents

Fremgangsmåder til modulering af celleoverfladereceptorer til at forebygge eller reducere inflammation

Info

Publication number
DK1971865T3
DK1971865T3 DK07709990.1T DK07709990T DK1971865T3 DK 1971865 T3 DK1971865 T3 DK 1971865T3 DK 07709990 T DK07709990 T DK 07709990T DK 1971865 T3 DK1971865 T3 DK 1971865T3
Authority
DK
Denmark
Prior art keywords
methods
prevent
cell surface
surface receptors
reduce inflammation
Prior art date
Application number
DK07709990.1T
Other languages
English (en)
Inventor
Prem Sreenivasan
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38017086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1971865(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Application granted granted Critical
Publication of DK1971865T3 publication Critical patent/DK1971865T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56955Bacteria involved in periodontal diseases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/18Dental and oral disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/26Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
DK07709990.1T 2006-01-10 2007-01-08 Fremgangsmåder til modulering af celleoverfladereceptorer til at forebygge eller reducere inflammation DK1971865T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75775106P 2006-01-10 2006-01-10
PCT/US2007/060222 WO2007082181A2 (en) 2006-01-10 2007-01-08 Methods of modulating cell surface receptors to prevent or reduce inflammation

Publications (1)

Publication Number Publication Date
DK1971865T3 true DK1971865T3 (da) 2013-07-08

Family

ID=38017086

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10153338.8T DK2177621T3 (da) 2006-01-10 2007-01-08 Fremgangsmåder til modulering af celleoverfladereceptorer til forebyggelse eller reduktion af inflammation
DK07709990.1T DK1971865T3 (da) 2006-01-10 2007-01-08 Fremgangsmåder til modulering af celleoverfladereceptorer til at forebygge eller reducere inflammation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK10153338.8T DK2177621T3 (da) 2006-01-10 2007-01-08 Fremgangsmåder til modulering af celleoverfladereceptorer til forebyggelse eller reduktion af inflammation

Country Status (17)

Country Link
US (1) US9157914B2 (da)
EP (2) EP1971865B1 (da)
JP (2) JP2009523029A (da)
CN (1) CN101371141A (da)
AR (1) AR058959A1 (da)
AU (1) AU2007204730B2 (da)
BR (1) BRPI0706505A2 (da)
CA (2) CA2635605C (da)
DK (2) DK2177621T3 (da)
ES (2) ES2431291T3 (da)
MY (1) MY151118A (da)
PH (1) PH12014501163A1 (da)
PL (2) PL1971865T3 (da)
RU (1) RU2431845C2 (da)
TW (2) TW201415028A (da)
WO (1) WO2007082181A2 (da)
ZA (1) ZA200805730B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2431291T3 (es) * 2006-01-10 2013-11-25 Colgate-Palmolive Company Métodos para modular receptores de superficie celular para prevenir o reducir la inflamación
TWI481870B (zh) * 2009-04-01 2015-04-21 Colgate Palmolive Co 用於軟組織疾病診斷及作為用於口腔保健干預的標靶之蛋白質生物標記
MX2011008959A (es) 2009-04-01 2011-09-27 Colgate Palmolive Co Compuestos carbonatos de anti-biopelicula para su uso en composiciones para el cuidado oral.
TWI405565B (zh) 2009-04-01 2013-08-21 Colgate Palmolive Co 口腔用組成物之抗-骨質流失及抗-牙周附連喪失之功效
JP5550717B2 (ja) 2009-04-01 2014-07-16 コルゲート・パーモリブ・カンパニー メントール誘導体ならびに口腔活性剤および全身活性剤としてのそれらの使用
EP3292216A1 (en) 2015-05-06 2018-03-14 The Procter and Gamble Company Detection of oral microbial virulence factors
US9964472B2 (en) 2016-06-29 2018-05-08 The Procter & Gamble Company Methods for sampling gingival metabolites
EP4018196A1 (en) * 2020-04-02 2022-06-29 Colgate-Palmolive Company Compositions for and methods of neutralizing lipopolysaccharide toxicity and methods of identifying the same

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) * 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
CA2176237A1 (en) 1993-11-10 1995-05-18 Richard P. Darveau Treatment of bacterially-induced inflammatory diseases
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
AUPN627595A0 (en) 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
JP2000512285A (ja) 1996-06-12 2000-09-19 ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチエン 化粧品および/または薬剤製剤
EP0863402B1 (en) 1997-03-03 2005-09-14 Amersham Biosciences UK Limited In-situ cell extraction and assay method
JP2000128900A (ja) 1998-10-26 2000-05-09 Japan Science & Technology Corp 新規トル様(Toll−like)レセプター及びその遺伝子
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
US6696261B2 (en) 1999-12-03 2004-02-24 Baxter International Inc. Pyrogenicity test for use with automated immunoassay systems
GB0001704D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
US20020009740A1 (en) 2000-04-14 2002-01-24 Rima Kaddurah-Daouk Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US7273712B2 (en) 2000-12-29 2007-09-25 Reddy Us Therapeutics, Inc. Methods and compositions for detecting compounds that modulate inflammatory responses
EP1414466B1 (en) 2001-07-09 2009-08-19 CombinatoRx, Incorporated Combinations for the treatment of inflammatory disorders
US6893828B2 (en) 2001-09-06 2005-05-17 Decode Genetics Ehf. Methods for producing ex vivo models for inflammatory disease and uses thereof
US7960398B2 (en) 2002-04-19 2011-06-14 Vertex Pharmaceuticals Incorporated Regulation of TNF-alpha
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
JP2006517969A (ja) 2003-02-14 2006-08-03 コンビナトアールエックス インコーポレーティッド 免疫炎症性障害の治療のための組み合わせ療法
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
WO2005039504A2 (en) 2003-10-24 2005-05-06 Eisai Co., Ltd. Compounds and methods for treating toll-like receptor 2-related diseases and conditions
JP2007519894A (ja) 2003-12-03 2007-07-19 ホワイトヘッド インスティテュート フォー バイオメディカル リサーチ 標的としてのカドヘリンの使用
JP2005304365A (ja) 2004-04-20 2005-11-04 Japan Science & Technology Agency Tlrリガンド及びil−1応答障害性モデル動物
FI20040572A0 (fi) 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
ES2431291T3 (es) * 2006-01-10 2013-11-25 Colgate-Palmolive Company Métodos para modular receptores de superficie celular para prevenir o reducir la inflamación
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
US8333981B2 (en) 2007-10-09 2012-12-18 Humco Holding Group, Inc. Antifungal treatment of nails

Also Published As

Publication number Publication date
AU2007204730B2 (en) 2011-11-17
RU2431845C2 (ru) 2011-10-20
DK2177621T3 (da) 2013-10-28
MY151118A (en) 2014-04-15
WO2007082181A2 (en) 2007-07-19
TW201415028A (zh) 2014-04-16
PL1971865T3 (pl) 2014-02-28
HK1141838A1 (en) 2010-11-19
BRPI0706505A2 (pt) 2011-03-29
CA2635605A1 (en) 2007-07-19
AU2007204730A1 (en) 2007-07-19
CA2635605C (en) 2014-07-08
CA2849559A1 (en) 2007-07-19
WO2007082181A3 (en) 2007-09-27
EP2177621B1 (en) 2013-10-09
EP1971865A2 (en) 2008-09-24
PH12014501163A1 (en) 2015-05-18
EP2177621A3 (en) 2010-09-08
JP2015051000A (ja) 2015-03-19
ZA200805730B (en) 2014-12-23
ES2421595T3 (es) 2013-09-04
US9157914B2 (en) 2015-10-13
ES2431291T3 (es) 2013-11-25
PL2177621T3 (pl) 2014-03-31
JP2009523029A (ja) 2009-06-18
US20070160544A1 (en) 2007-07-12
EP2177621A2 (en) 2010-04-21
AR058959A1 (es) 2008-03-05
HK1121235A1 (en) 2009-04-17
EP1971865B1 (en) 2013-04-17
CN101371141A (zh) 2009-02-18
TW200801514A (en) 2008-01-01
RU2008132839A (ru) 2010-02-20

Similar Documents

Publication Publication Date Title
DK3524316T3 (da) Elektroporationsanordning til elektroporation af celler i pattedyr
EP1979951A4 (en) SOLAR CELL
EP2211411A4 (en) Fuel cell system
DE102008055028A8 (de) Solarzelle
EP2095430A4 (en) SOLAR CELL
IT1392792B1 (it) Impianto fotovoltaico galleggiante
PL2247391T3 (pl) Warstwa podkładowa dla modułów fotowoltaicznych
DK2140499T3 (da) Solmodul til skråtag
BRPI0816956A2 (pt) Célula de combustível
EP2176171A4 (en) Separator tank
DE602008000048D1 (de) Brennstoffzelle
DK2277222T3 (da) Brændselscellesystem
DK1971865T3 (da) Fremgangsmåder til modulering af celleoverfladereceptorer til at forebygge eller reducere inflammation
DE112007001371B8 (de) Brennstoffzelle
DE112007002407B8 (de) Brennstoffzelle
DE112009002696T8 (de) Brennstoffzellensystem
EP2318710A4 (en) STRENGTHED CONNECTION FOR WIND TURBINE
EP2362470A4 (en) FUEL CELL
DE602008006153D1 (de) Einkristall-turbinenschaufel
DE102008055036A8 (de) Solarzelle
DE602008002852D1 (de) Brennstoffzellsystem
EP2234480A4 (en) LIQUID CONSERVATIVE COMPOSITIONS
DK2183042T3 (da) Væskeseparator
FI20075699L (fi) Polttokennolaitteisto
DE602007007302D1 (de) Brennstoffzelle